These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11961154)

  • 1. Successful gene therapy for severe combined immunodeficiency.
    Rosen FS
    N Engl J Med; 2002 Apr; 346(16):1241-3. PubMed ID: 11961154
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gene therapy of severe combined immunodeficiencies].
    Cavazzana-Calvo M; Hacein-Bey S; de Saint-Basile G; Le Deist F; Fischer A
    Transfus Clin Biol; 2000 Jun; 7(3):259-60. PubMed ID: 10919216
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy. The best of times, the worst of times.
    Anderson WF
    Science; 2000 Apr; 288(5466):627-9. PubMed ID: 10799000
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy of severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Le Deist F; De Saint Basile G; Cavazzana-Calvo M
    Adv Exp Med Biol; 2001; 495():199-204. PubMed ID: 11774567
    [No Abstract]   [Full Text] [Related]  

  • 5. Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID).
    Leonard WJ; Noguchi M; Russell SM
    Adv Exp Med Biol; 1994; 365():225-32. PubMed ID: 7887307
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy for XSCID: the first success of gene therapy.
    Kohn DB
    Pediatr Res; 2000 Nov; 48(5):578. PubMed ID: 11044472
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Bubble boy' paradox resolved.
    Nowak R
    Science; 1993 Dec; 262(5141):1818. PubMed ID: 8266068
    [No Abstract]   [Full Text] [Related]  

  • 8. The defective gene in X-linked severe combined immunodeficiency encodes a shared interleukin receptor subunit: implications for cytokine pleiotropy and redundancy.
    Leonard WJ
    Curr Opin Immunol; 1994 Aug; 6(4):631-5. PubMed ID: 7946053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene therapy for severe combined immunodeficiency linked to chromosome X].
    Fischer A
    Hematol Cell Ther; 1997 Apr; 39(2):97. PubMed ID: 9229544
    [No Abstract]   [Full Text] [Related]  

  • 10. X-linked severe combined immunodeficiency: from molecular cause to gene therapy within seven years.
    Leonard WJ
    Mol Med Today; 2000 Oct; 6(10):403-7. PubMed ID: 11006530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling.
    Leonard WJ
    Annu Rev Med; 1996; 47():229-39. PubMed ID: 8712778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine lymphocyte expression of retrovirally transferred human common gamma chain.
    Whitwam T; Haskins ME; Henthorn PS; Bodine DM; Puck JM
    Ann N Y Acad Sci; 1999 Apr; 872():387-90. PubMed ID: 10372141
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacillus species infection of the skin as a presentation of severe combined immunodeficiency disease.
    Machado LS; Sleasman JW; Ford MJ
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):285-7. PubMed ID: 9704850
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway.
    Candotti F; O'Shea JJ; Villa A
    Springer Semin Immunopathol; 1998; 19(4):401-15. PubMed ID: 9618765
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.
    Hacein-Bey-Abina S; Le Deist F; Carlier F; Bouneaud C; Hue C; De Villartay JP; Thrasher AJ; Wulffraat N; Sorensen R; Dupuis-Girod S; Fischer A; Davies EG; Kuis W; Leiva L; Cavazzana-Calvo M
    N Engl J Med; 2002 Apr; 346(16):1185-93. PubMed ID: 11961146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.
    Stephan V; Wahn V; Le Deist F; Dirksen U; Broker B; Müller-Fleckenstein I; Horneff G; Schroten H; Fischer A; de Saint Basile G
    N Engl J Med; 1996 Nov; 335(21):1563-7. PubMed ID: 8900089
    [No Abstract]   [Full Text] [Related]  

  • 17. Retroviral gene therapy--where now?
    Günzburg WH
    Trends Mol Med; 2003 Jul; 9(7):277-8. PubMed ID: 12900211
    [No Abstract]   [Full Text] [Related]  

  • 18. Recipient T-cell immune reconstitution in X-linked SCID after haploidentical maternal bone marrow transplant.
    de la Morena MT; Wayne AS; Day NK; Haag MM; Hinds-Frey KR; Nelson RP; Sutcliffe MJ; Good RA
    Ann N Y Acad Sci; 1995 Dec; 770():376-7. PubMed ID: 8597380
    [No Abstract]   [Full Text] [Related]  

  • 19. [Successful gene therapy of children with severe immunodeficiency. Research breakthrough hopefully for the treatment of other diseases, too].
    Fasth A; Mellgren K; Karlsson S; Richter J
    Lakartidningen; 2002 Jul; 99(28-29):3010-2. PubMed ID: 12170507
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene therapy of severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Le Deist F; Soudais C; Di Santo JP; de Saint Basile G; Cavazzana-Calvo M
    Immunol Rev; 2000 Dec; 178():13-20. PubMed ID: 11213798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.